Passage Bio
PASG
PASG
43 hedge funds and large institutions have $32M invested in Passage Bio in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
41% less capital invested
Capital invested by funds: $54.4M → $32M (-$22.4M)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Holders
43
Holding in Top 10
3
Calls
$7K
Puts
–
Top Buyers
| 1 | +$1.23M | |
| 2 | +$168K | |
| 3 | +$37.2K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10.5K |
| 5 |
AI
Acuitas Investments
Seattle,
Washington
|
+$2K |
Top Sellers
| 1 | -$741K | |
| 2 | -$283K | |
| 3 | -$191K | |
| 4 |
Millennium Management
New York
|
-$91.2K |
| 5 |
BlackRock
New York
|
-$83.4K |